SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-91 days |
20 |
61.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69121 |
1126 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 42 and 91 days) and controlled sodium content drinking water (1 %) (between 42 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 42 and 91 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
81 days-133 days |
33 |
20.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69123 |
1126 |
SHR/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (for 140 days) and controlled sodium content drinking water (1 %) (for 140 days) and controlled potassium content diet (6.3 mg/g) (for 140 days) |
Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34 |
cerebrovascular system integrity trait |
both |
182 days
| 30 |
20.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69118 |
1125 |
SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 28 and 67 days) and controlled sodium content drinking water (1 %) (between 28 and 67 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 67 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-109 days |
33 |
100.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
84575 |
1126 |
SHRSP/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days) |
Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34 |
cerebrovascular system integrity trait |
both |
84 days
| 30 |
100.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69117 |
1125 |
SHRSP/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 70 and 88 days) and controlled sodium content drinking water (1 %) (between 70 and 88 days) and controlled potassium content diet (6.3 mg/g) (between 70 and 88 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-88 days |
31 |
100.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69119 |
1126 |
SHRSR/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
126 days
| 18 |
0.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69120 |
1126 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-91 days |
34 |
63.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69122 |
1126 |
SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 42 and 91 days) and controlled sodium content drinking water (1 %) (between 42 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 42 and 91 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
81 days-133 days |
31 |
20.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
69124 |
1126 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 28 and 91 days) and controlled sodium content drinking water (1 %) (between 28 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 91 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-133 days |
35 |
100.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
0 |
84576 |
1126 |